TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34134579

Group type: EXPERIMENTAL
Intervention: Adalimumab injecta (40 mg)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Humira® (40 mg)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Adalimumab injecta
Number of subjects: 164

Group type: COMPARATOR
Intervention: Humira®
Number of subjects: 164
Study: 34735452

Group type: EXPERIMENTAL
Intervention: Dissonance-based group intervention conducted three months post-RYGB, consisting of four group sessions.
Number of subjects: 259

Group type: COMPARATOR
Intervention: Standard post-surgery care (control group).
Number of subjects: 259
Study: 35057579

Group type: EXPERIMENTAL
Intervention: 250 mL baobab aqueous extract (BAE)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (oral glucose tolerance test (OGTT))
Number of subjects: 31
Study: 34526321

Group type: EXPERIMENTAL
Intervention: Household-based community health worker programme
Number of subjects: 120000
Study: 34758210

Group type: EXPERIMENTAL
Intervention: Peer-delivered group cognitive-behavioral therapy (CBT) for postpartum depression (PPD)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 73
Study: 33849091

Group type: EXPERIMENTAL
Intervention: EVOSKIN PSMC
Number of subjects: 105

Group type: COMPARATOR
Intervention: Physiological saline
Number of subjects: 105
Study: 34633116

Group type: EXPERIMENTAL
Intervention: Romosozumab 210 mg sc every month for 2 months
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 34870069

Group type: EXPERIMENTAL
Intervention: Gym participation program for 6 months
Number of subjects: 19
Study: 32493881

Group type: EXPERIMENTAL
Intervention: Prasugrel (3.75 mg/day)
Number of subjects: 3753

Group type: COMPARATOR
Intervention: Clopidogrel (75 mg/day)
Number of subjects: 3753
Study: 36286886

Group type: EXPERIMENTAL
Intervention: Bismuth-based quadruple therapy with Bifiform (omeprazole 20 mg, amoxicillin 1000 mg, clarithromycin 500 mg, bismuth tripotassium dicitrate 240 mg, Bifiform 2 capsules 2 times a day for 14 days)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group therapy (same as main group but without Bifiform)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Bismuth-based quadruple therapy with Bifiform
Number of subjects: 68
Study: 35415940

Group type: EXPERIMENTAL
Intervention: M‐MIST alone
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: M‐MIST + EMD
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: M‐MIST + EMD + BMDX
Number of subjects: 45
Study: 33277803

Group type: EXPERIMENTAL
Intervention: Platelet count (PLT) > 105 × 10^9/L
Number of subjects: 436

Group type: COMPARATOR
Intervention: Baveno VI criteria
Number of subjects: 436
Study: 33542229

Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI)
Number of subjects: 7489

Group type: EXPERIMENTAL
Intervention: Waist-to-Hip Ratio (WHR)
Number of subjects: 7489
Study: 34253806

Group type: EXPERIMENTAL
Intervention: Cold bubbled humidified oxygen therapy (OX + HUMID)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cold bubbled humidified compressed air (CA + HUMID)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Dry oxygen therapy (OX + DRY)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Dry compressed air (CA + DRY)
Number of subjects: 31
Study: 33167877

Group type: EXPERIMENTAL
Intervention: Very Early Supported Discharge (VESD)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard Discharge
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Self-confidence in postural balance
Number of subjects: 140

Group type: COMPARATOR
Intervention: Very Early Supported Discharge (VESD) and Standard Discharge
Number of subjects: 140
Study: 36499313

Group type: EXPERIMENTAL
Intervention: Cenerimod 0.5 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cenerimod 4 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: COC alone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: COC with cenerimod 4 mg
Number of subjects: 24
Study: 33416994

Group type: EXPERIMENTAL
Intervention: Anterior approach CISB
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Posterior approach CISB
Number of subjects: 54

Group type: COMPARATOR
Intervention: Catheters with tip migration
Number of subjects: 54
Study: 34299962

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation through telerehabilitation tools
Number of subjects: 40

Group type: COMPARATOR
Intervention: No physical activity (Control group)
Number of subjects: 40
Study: 32191595

Group type: EXPERIMENTAL
Intervention: Effleurage massage (5 minutes)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (no massage)
Number of subjects: 32
Study: 35381080

Group type: EXPERIMENTAL
Intervention: Antibiotics (intravenous ertapenem followed by oral levofloxacin and metronidazole)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 33752446

Group type: EXPERIMENTAL
Intervention: Acupuncture (n = 50)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I) (n = 37)
Number of subjects: 160
Study: 35201260

Group type: EXPERIMENTAL
Intervention: Integrating Machine Learning Mortality Estimates with Behavioral Nudges to Clinicians
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 33781638

Group type: EXPERIMENTAL
Intervention: Closed-incision negative-pressure therapy (ciNPT)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Silver-impregnated antimicrobial dressing (AMD)
Number of subjects: 294
Study: 34986178

Group type: EXPERIMENTAL
Intervention: PHiD-CV10
Number of subjects: 45398

Group type: COMPARATOR
Intervention: Control (hepatitis B/A vaccine)
Number of subjects: 45398
Study: 35932699

Group type: EXPERIMENTAL
Intervention: Robotic cat therapy (20 min/week for 2 months)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Betta fish therapy (kept at home for 2 months)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study: 33395924

Group type: EXPERIMENTAL
Intervention: Salbutamol (SAL) 400 µg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Diesel exhaust (DE) exposure
Number of subjects: 19
Study: 32043907

Group type: EXPERIMENTAL
Intervention: Inotersen 300 mg/week
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 35072273

Group type: EXPERIMENTAL
Intervention: Presence of a female experimenter
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Presence of a male experimenter
Number of subjects: 299

Group type: COMPARATOR
Intervention: No experimenter present
Number of subjects: 299
Study: 33851246

Group type: EXPERIMENTAL
Intervention: Outpatient physical therapy (superficial heater + deep heater + transcutaneous electrical nerve stimulation) for 2 weeks and spa therapy
Number of subjects: 74

Group type: COMPARATOR
Intervention: Inpatient physical therapy (superficial heater + deep heater + transcutaneous electrical nerve stimulation) for 2 weeks and spa therapy
Number of subjects: 74
Study: 36191949

Group type: EXPERIMENTAL
Intervention: Glimepiride
Number of subjects: 8252

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 8252

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 8252
Study: 34165343

Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGM)
Number of subjects: 0
Study: 32234653

Group type: EXPERIMENTAL
Intervention: Low-protein formula (1.89 g protein/100 kcal)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High-protein formula (2.1 g protein/100 kcal)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Breast-fed reference group
Number of subjects: 80
Study: 34238227

Group type: EXPERIMENTAL
Intervention: cFMT (frozen encapsulated fecal microbiota transplantation)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham treatment (placebo)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: cFMT
Number of subjects: 12
Study: 32740903

Group type: EXPERIMENTAL
Intervention: Intravenous sodium valproate (iVPA)
Number of subjects: 682
Study: 36206023

Group type: EXPERIMENTAL
Intervention: Kinect Adventures games
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional physiotherapy protocol
Number of subjects: 38
Study: 34311597

Group type: EXPERIMENTAL
Intervention: CPITN-1 in stage 1 CKD
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: CPITN-2 in stage 1 CKD
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: CPITN-3 in stage 1 CKD
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: CPITN-4 in stage 1 CKD
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: CPITN-1 in stage 2 CKD
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: CPITN-2 in stage 2 CKD
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: CPITN-3 in stage 2 CKD
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: CPITN-4 in stage 2 CKD
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: CPITN-1 in stage 3 CKD
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: CPITN-2 in stage 3 CKD
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: CPITN-3 in stage 3 CKD
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: CPITN-4 in stage 3 CKD
Number of subjects: 1159
Study: 32125665

Group type: EXPERIMENTAL
Intervention: Finerenone 20 mg orally
Number of subjects: 82
Study: 35170528

Group type: EXPERIMENTAL
Intervention: Lamivudine and adefovir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guide with age, gender, HBV DNA, core promoter mutations and cirrhosis (GAG-HCC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Taiwanese HBV cohort (TW1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: REACH-B
Number of subjects: 0
Study: 34911689

Group type: EXPERIMENTAL
Intervention: Induction group
Number of subjects: 136

Group type: COMPARATOR
Intervention: Expectant management group
Number of subjects: 136
Study: 35509110

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser followed by triamcinolone acetonide application
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Microneedling followed by triamcinolone acetonide application
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison between fractional CO2 laser and microneedling
Number of subjects: 30
Study: 32091597

Group type: EXPERIMENTAL
Intervention: AHEI-2010 second quintile
Number of subjects: 8461

Group type: EXPERIMENTAL
Intervention: AHEI-2010 third quintile
Number of subjects: 8461

Group type: EXPERIMENTAL
Intervention: AHEI-2010 fourth quintile
Number of subjects: 8461

Group type: EXPERIMENTAL
Intervention: AHEI-2010 fifth quintile
Number of subjects: 8461
Study: 37442218

Group type: EXPERIMENTAL
Intervention: Swiss ball stabilization training (SBST)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Stable surface stabilization training (SSST)
Number of subjects: 30
Study: 33583360

Group type: EXPERIMENTAL
Intervention: Cecolin® vaccine with ISARs (local pain, induration, swelling, systemic fever)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cecolin® vaccine without ISARs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cecolin® vaccine (high ISAR score)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hepatitis E vaccine
Number of subjects: 0
Study: 32562682

Group type: EXPERIMENTAL
Intervention: Medical management alone
Number of subjects: 226

Group type: COMPARATOR
Intervention: Medical management plus interventional therapy
Number of subjects: 226
Study: 34609621

Group type: EXPERIMENTAL
Intervention: PROT (advice to increase protein intake to ≥ 1.2 g/kg aBW/d)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: PROT + TIMING (similar advice plus advice to consume protein-enriched foods within half an hour after usual physical activity)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: PROT
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: PROT + TIMING
Number of subjects: 276

Group type: COMPARATOR
Intervention: CON (continue the habitual diet with no advice)
Number of subjects: 276
Study: 33704808

Group type: EXPERIMENTAL
Intervention: Genetically proxied LDL-c levels
Number of subjects: 173082

Group type: COMPARATOR
Intervention: Survival to the 90th vs 60th percentile age
Number of subjects: 173082

Group type: EXPERIMENTAL
Intervention: LDL-c modification through PCSK9
Number of subjects: 173082
Study: 34988957

Group type: EXPERIMENTAL
Intervention: Serratus anterior plane block (SAPB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Infiltration block
Number of subjects: 60
Study: 33509352

Group type: EXPERIMENTAL
Intervention: Short taper of steroids over 36 days after remission
Number of subjects: 0
Study: 32326966

Group type: EXPERIMENTAL
Intervention: Hemp seed protein (HSP)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Hemp seed protein plus HSP hydrolysate (HSP+)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Casein protein
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: All treatments (HSP, HSP+, Casein)
Number of subjects: 35
Study: 34704428

Group type: EXPERIMENTAL
Intervention: Moderate intensity resistance training with blood flow restriction at 50 mmHg
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Moderate intensity resistance training with blood flow restriction at 75 mmHg
Number of subjects: 39

Group type: COMPARATOR
Intervention: Exercise training without restrictive pressure (Control group A)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 39
Study: 33159971

Group type: EXPERIMENTAL
Intervention: Dummy run brachytherapy planning
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Annual quality assurance
Number of subjects: 27
Study: 32501914

Group type: EXPERIMENTAL
Intervention: Intravenous EACA
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 24
Study: 33094434

Group type: EXPERIMENTAL
Intervention: High sensitivity C reactive protein (hs‐CRP) levels in bipolar disorder patients
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: hs‐CRP elevation in bipolar patients
Number of subjects: 56
Study: 32600060

Group type: EXPERIMENTAL
Intervention: Robot Assisted Kidney Transplant (RAKT)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Open Kidney Transplant (OKT)
Number of subjects: 55
Study: 35965631

Group type: EXPERIMENTAL
Intervention: Continuous care combined with respiratory exercise care model
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional care methods
Number of subjects: 120
Study: 34314254

Group type: EXPERIMENTAL
Intervention: Chosen sound for 2 weeks
Number of subjects: 33

Group type: COMPARATOR
Intervention: Study sound (broadband noise at hearing threshold) for 2 weeks
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Chosen sound
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: App usage during at-home trial
Number of subjects: 33
Study: 33158856

Group type: EXPERIMENTAL
Intervention: Values affirmation exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 35166684

Group type: EXPERIMENTAL
Intervention: Smartband (Mi Band 2) and app (Mi Fit) with midwife counseling
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 150
Study: 33653815

Group type: EXPERIMENTAL
Intervention: Antidiabetic drug users (including insulin and metformin)
Number of subjects: 6537

Group type: EXPERIMENTAL
Intervention: Antidiabetic drug users
Number of subjects: 6537

Group type: COMPARATOR
Intervention: Nonusers of antidiabetic medication
Number of subjects: 6537
Study: 32062808

Group type: EXPERIMENTAL
Intervention: Choroidal vascularity index (CVI) measurement in FUS eyes
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Endothelial cell density (ECD) measurement in FUS eyes
Number of subjects: 39
Study: 34914216

Group type: EXPERIMENTAL
Intervention: Tadalafil combined with behavioral therapy and psychological counseling
Number of subjects: 338

Group type: COMPARATOR
Intervention: Tadalafil alone
Number of subjects: 338
Study: 35502334

Group type: EXPERIMENTAL
Intervention: Lidocaine as a local anesthetic at the puncture site prior to IVC
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (no lidocaine)
Number of subjects: 77
Study: 32628523

Group type: EXPERIMENTAL
Intervention: Flipped classroom intervention in respiratory pathophysiology (2018)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Flipped classroom intervention for students scoring below the median
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Flipped classroom intervention for male students
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Flipped classroom intervention for students without academic delay
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Flipped classroom intervention overall perception
Number of subjects: 201

Group type: COMPARATOR
Intervention: Traditional teaching method in blood pathophysiology (2017 and 2018)
Number of subjects: 201
Study: 35543710

Group type: EXPERIMENTAL
Intervention: Pulmonary Rehabilitation (PR) - outpatient, three weekly sessions for 3 months
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control intervention (usual care + airway clearance therapy + breathing exercises)
Number of subjects: 41
Study: 33896810

Group type: EXPERIMENTAL
Intervention: Kinetic Control training (n=9)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (n=9)
Number of subjects: 18
Study: 33502222

Group type: EXPERIMENTAL
Intervention: Bowel Ischemia Score (BIS) of 0 or 1
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Bowel Ischemia Score (BIS) of 3
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Bowel Ischemia Score (BIS)
Number of subjects: 275
Study: 32188284

Group type: EXPERIMENTAL
Intervention: Barbed sutures (running closure)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard of care sutures (interrupted closure)
Number of subjects: 60
Study: 34726144

Group type: EXPERIMENTAL
Intervention: High-in Warning Labels (HIWL)
Number of subjects: 22140

Group type: EXPERIMENTAL
Intervention: Health Star Ratings (HSR)
Number of subjects: 22140

Group type: EXPERIMENTAL
Intervention: Guideline Daily Amounts (GDA)
Number of subjects: 22140

Group type: EXPERIMENTAL
Intervention: Multiple Traffic Lights
Number of subjects: 22140

Group type: EXPERIMENTAL
Intervention: Health Warning Labels
Number of subjects: 22140

Group type: COMPARATOR
Intervention: No label control
Number of subjects: 22140
Study: 32324693

Group type: EXPERIMENTAL
Intervention: Facilitated mobilization (staff dedicated to assist transfers and walking during hospital stay)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Facilitated mobilization
Number of subjects: 99

Group type: COMPARATOR
Intervention: Usual care (preoperative education)
Number of subjects: 99
Study: 33867254

Group type: EXPERIMENTAL
Intervention: NoGo-Alcohol
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: NoGo-Neutral
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Go-Alcohol
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Go-Neutral
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: N2 component
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: P3 component
Number of subjects: 59
Study: 34847900

Group type: EXPERIMENTAL
Intervention: Counseling with hope therapy (8 sessions of 45 minutes, twice a week)
Number of subjects: 52
Study: 36032228

Group type: EXPERIMENTAL
Intervention: Shared Decision Making (SDM) training program for clinicians based on the Japanese MDD guidelines
Number of subjects: 124

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 124
Study: 33377898

Group type: EXPERIMENTAL
Intervention: Remote intensive management (RIM) by allied health care practitioners
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Remote intensive management (RIM)
Number of subjects: 301
Study: 32395828

Group type: EXPERIMENTAL
Intervention: 2-week practice (TWP)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 8-week practice (EWP)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Both groups (TWP and EWP)
Number of subjects: 15
Study: 35440333

Group type: EXPERIMENTAL
Intervention: Evening primrose vaginal capsule (500 mg) used vaginally, two doses
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 33625502

Group type: EXPERIMENTAL
Intervention: Peer-delivered self-management intervention (self-help book and telephone-based peer counseling) in addition to care as usual (CAU)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Peer-delivered self-management intervention
Number of subjects: 89
Study: 33461615

Group type: EXPERIMENTAL
Intervention: Consistent condom use during anal and vaginal intercourse
Number of subjects: 227

Group type: COMPARATOR
Intervention: Any STI including HIV
Number of subjects: 227

Group type: COMPARATOR
Intervention: Any STI except HIV
Number of subjects: 227

Group type: COMPARATOR
Intervention: HIV
Number of subjects: 227

Group type: COMPARATOR
Intervention: Chlamydia
Number of subjects: 227

Group type: COMPARATOR
Intervention: Gonorrhea
Number of subjects: 227

Group type: COMPARATOR
Intervention: Syphilis
Number of subjects: 227

Group type: COMPARATOR
Intervention: Hepatitis B
Number of subjects: 227

Group type: COMPARATOR
Intervention: Hepatitis C
Number of subjects: 227
Study: 35116567

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 168

Group type: COMPARATOR
Intervention: Micro-electroacupuncture (control)
Number of subjects: 168
Study: 33292046

Group type: COMPARATOR
Intervention: Biomarkers measured using OLINK proximity extension assay panels and conventional immunoassays.
Number of subjects: 5607
Study: 36030313

Group type: EXPERIMENTAL
Intervention: Retrievable vena cava filters
Number of subjects: 223

Group type: COMPARATOR
Intervention: Control group (no retrievable vena cava filters)
Number of subjects: 223
Study: 36126255

Group type: EXPERIMENTAL
Intervention: Midazolam (5 mg)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Morphine (5 mg)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Morphine-Midazolam (5 mg each)
Number of subjects: 84
Study: 33126555

Group type: COMPARATOR
Intervention: Physical Activity (PA)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Physical Activity plus Weight Loss (PA + WL)
Number of subjects: 155
Study: 34552033

Group type: EXPERIMENTAL
Intervention: Menthol-based topical analgesic
Number of subjects: 16
Study: 35583116

Group type: EXPERIMENTAL
Intervention: 7 days of antibiotics
Number of subjects: 106
Study: 33184979

Group type: EXPERIMENTAL
Intervention: oral semaglutide (4-week dose escalation from 3 to 7 to 14 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: oral semaglutide
Number of subjects: 15

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15